Small Intestinal Bacterial Overgrowth Obese (NCT02819037) | Clinical Trial Compass
CompletedNot Applicable
Small Intestinal Bacterial Overgrowth Obese
France51 participantsStarted 2016-05-27
Plain-language summary
The objective of this research is to determine the incidence of microbial overgrowth of the small intestine before and after a gastric bypass. For this purpose, the study is based on the analysis of the expired hydrogen H2 with gas chromatography before surgery and at 1, 3, 6, 12, 18 and 24 months.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Severe obesity (BMI\>35kg/m² with at least one comorbidity or BMI\>40kg/m² without comorbidity) and after medical care for at least 6 months
* Patient who will follow bariatric surgery by bypass gastric
* Social insurance affiliation
* Signature of the informed consent
Exclusion Criteria:
* Contraindication criteria for bariatric surgery (cognitive or mental severe disorders, severe and non-stabilized eating disorders, etc.)
* Chronic inflammatory bowel disease (Crohn's disease, hemorrhagic rectocolitis)
* Previous intestinal surgery
* Antibiotic periodicity treatment of less than 3 months
* Other diseases responsible for bacterial overgrowth
* Pregnancy or breastfeeding